Earnings Alerts

Converge Technology Solutions (CTS) Earnings Forecast: 4Q Results Show Potential High Ebitda and Gross Profit

By February 7, 2025 No Comments
  • Converge Technology forecasts its adjusted EBITDA for the 4th quarter to be at the high end of the C$36 million to C$47 million range.
  • The market’s estimate for Converge Technology’s adjusted EBITDA is C$39.1 million.
  • The company’s expected gross profit for the 4th quarter is also at the high end, within the range of C$165 million to C$178 million.
  • Converge Technology maintains positive sentiment with 7 buy ratings, 4 hold ratings, and 0 sell ratings from analysts.

A look at Converge Technology Solutions Smart Scores

FactorScoreMagnitude
Value3
Dividend2
Growth2
Resilience2
Momentum2
OVERALL SMART SCORE2.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Converge Technology Solutions Corp. has been assessed using Smartkarma Smart Scores, with ratings of 3 for Value, 2 for Dividend, Growth, Resilience, and Momentum. This indicates a balanced outlook for the company across various factors. Being rated above average for value suggests that the company’s stock may be priced reasonably compared to its intrinsic value. However, with lower scores for dividend, growth, resilience, and momentum, investors may need to consider other aspects of the company’s performance for a comprehensive investment decision.

Providing information technology services, Converge Technology Solutions focuses on multi-cloud, identity management, resiliency, security, and data center solutions for businesses in Canada and the United States. While the Smart Scores give a snapshot of the company’s overall outlook, investors should conduct further research to understand the specifics of Converge’s financial health, market position, and growth prospects before making investment decisions.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars